American Journal of Infection Control

Approximately 495,000 individuals receive maintenance hemodialysis (HD) for end-stage renal disease annually in the United States.1 These patients are at high risk for infection because of impaired immune defenses, and the need for routine vascular

Disproportionately high rates of COVID-19 infection among health workers prompts the need to identify the risk factors to help guide the design and implementation of interventions. The aim of this study was to characterize the risk factors for COVID

Strengthening infection prevention and control programs in non-acute care settings is a national priority. Efforts require thorough and ongoing appraisal of organizational structures, human resources including personnel training and competencies

University Hospitals Parma Medical Center (UHPMC) in Parma, Ohio is an adult suburban hospital with 247 licensed beds that is striving to reach a goal of zero harm for all patients. Many hospital systems nationally are aiming to decrease hospital

The Centers for Medicare and Medicaid Services (CMS) implemented requirements for public reporting of device-related healthcare-associated infections (HAIs) under the Hospital Inpatient Quality Reporting Program; this program required public

Acinetobacter baumannii complex (ABC), a group of aerobic nonfermenting Gram-negative coccobacilli, has become one of the most prominent opportunistic nosocomial pathogens. It causes severe nosocomial infections worldwide, especially in intensive

Midline catheters (midlines) have emerged as an alternative to peripherally inserted central catheters (PICCs) when short-term venous access is needed for peripherally compatible infusates. Midlines are inserted in the antecubital fossa or the upper

Acinetobacter baumannii complex (ABC), a group of aerobic non-fermenting Gram-negative coccobacilli, has become one of the most prominent opportunistic nosocomial pathogens. It causes severe nosocomial infections worldwide, especially in intensive

Antibiotic overuse puts patients at risk for adverse events and contributes to global antibiotic resistance. More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.1

The coronavirus disease (COVID-19) is a highly contagious illness caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).1,2 Among the primary measures to reduce COVID-19 dissemination, multiple health authorities, including the